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A  variety  of substances,  many of them  of bacterial  origin,  stimulate  murine  B 
lymphocytes polyclonally to growth, and to maturation into a state of Ig secretion (1). 
We  have  previously  found,  under  improved  tissue-culture  conditions  for  murine 
lymphocytes (2,  3), that one of three splenic B  lymphocytes can be stimulated as a 
single precursor to the clonal growth and maturation of >100 IgM-secreting cells per 
clone in vitro (4,  5)  by the mitogens lipopolysaccharide (LPS) 1 (6), lipoprotein  (LP) 
(7), and Nocardia (NOC)  (8). A major part of all these splenic B cells has, as mitogen- 
activated blasts, reactivities, and therefore probably receptors, for more than one of 
these mitogens. Thus, a large part of all blasts generated by a first mitogen that needs 
the continuous  presence of mitogen for further clonal growth can continue  to grow 
with another mitogen (9). 
We show in this paper that PPD, the purified protein derivative of tuberculin (PPD 
tuberculin)  is a B-cell mitogen (10) for only activated B-cell blasts, but not for resting, 
small  B  lymphocytes.  Thus,  small,  resting  B  cells  from  mouse  spleen  purified  by 
velocity sedimentation  (11)  are not  activated to growth, whereas  the  medium- and 
large-size cells from spleen containing background plaque-forming cells (PFC)  (5), as 
well as B-cell blasts generategl by the mitogen LPS, can continue to grow and mature 
into  IgM-secreting  PFC  (IgM-PFC)  in  large  numbers  in  the  presence  of  PPD 
tuberculin. We, therefore, now distinguish between some mitogens, such as LPS, LP, 
or NOC which can stimulate resting cells and activated blasts to growth and others, 
such as PPD tuberculin, which can only stimulate activated blasts. Small B cells, on 
the  other  hand,  do  not  remain  in  their  resting  state  after  treatment  with  PPD 
tuberculin, but are activated to the blast state in which they secrete Ig molecules, in 
the absence of cellular DNA-synthesis. PPD tuberculin,  therefore, can distinguish in 
its stimulatory action reactions in B cells leading to maturation into Ig secretion, from 
those leading to growth. 
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1 Abbreviations used in this paper: BSS, balanced salt solution; Go, resting state of the cell cycle; Gx, cell- 
cycle phase of an activated cell after mitosis and before DNA synthesis; G2, cell-cycle  phase of an activated 
cell after DNA synthesis and before mitosis; HRC, horse erythrocytes; IgM-PFC, IgM-secreting  plaque- 
forming  cells; LP, lipoprotein; LPS, lipopolysaccharide;  M, mitosis; NO(], Nocardia; PFC, plaque-forming 
cell(s); PPD tuberculin, purified protein derivative of tuberculin; S-phase, DNA-synthesis phase; SRC, 
sheep erythrocyte(s);  TNP~0-SRC, trinitrophenyl-substituted SRC. 
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Materials  and  Methods 
Animals.  C57BL/6J F1 nu/nu mice, 6-8 wk of age, and Lewis strain rats, 4 wk of age, were 
obtained from the Institut f/fir Biologisch-Medizinische Forschung A.G., F/illinsdorf, Switzer- 
land. 
Cell Cultures.  Mouse spleen cells were prepared as described previously (2, 3) and cultured 
in a modified Dulbecco's-modified Eagle's medium containing albumin, transferrin, and which 
contained soybean lipid (12)  (instead of fetal calf serum),  2-mercaptoethanol (5  X  10  -5 M), 
and  kanamycin (Gibco Bio-Cult, Irvine, Scotland).  Mass cultures were  initiated at  3  ×  105 
cells/ml. Cultures at limiting dilutions of reactive B cells contained 3 X  106 rat thymus cells/ 
ml as growth-supporting filler cells (2). Separation of cells of different size was done by velocity 
sedimentation using a gradient of 2-4% bovine serum albumin (Sigma Chemical Co., St. Louis, 
Mo.) in balanced salt solution (BSS)  (11). After separation cell fractions were washed with BSS 
and then either recultured in mass cultures at  1-3 ×  10  ~ cells/ml or in limiting dilutions in 3 
×  106 rat filler cells/ml (Results). To minimize contaminations of medium- and large-size cells 
in the small cells fractions, cells in the ascending part of the peak of small cells, near the peak 
of  •  •  •  6  the even smaller erythrocytes (11), were taken. In a typxcal separatxon experiment, 10  cells 
of a selected fraction of small cells incorporated < 15 cpm [3H]thymidine (2 Ci/mMol, 10 #Ci/ 
ml)  in  1 h  into  acid-precipitable material,  and  contained  100-600  background  IgM-PFC. 
Selected fractions of medium- and large-size cells incorporated 750-3,000 cpm [3H]thymidine 
and contained 1-5 ×  104 background IgM-PFC, whereas 106 original, unseparated spleen cells 
incorporated 150-300 cpm [3H]thymidine and contained 2-8 ×  103 background IgM-PFC. 
Mitogens.  The smooth form of LPS from Salmonella abortus-equi  was kindly prepared for us by 
Dr. C. Galanos and Dr. O. Liideritz, Max Planck Institut ffir Immunbiologie, Freiburg, West 
Germany. It was routinely used at 50 #g/ml in cultures. Both small, resting B cells as well as B- 
cell blasts showed  their optimum  activation at  this concentration.  Several batches of PPD 
tuberculin  (Results)  were  obtained  from  Statens  Serum  Institute,  Copenhagen,  Denmark. 
Unless specified in the Results, they were routinely used at  100/~g/ml in cultures. 
Assays.  Cell  concentrations  in  culture  were  determined  with  a  Biirker hemocytometer. 
Cultures were assayed for the number of cells secreting either IgM or IgG1 and IgG2 by the 
protein A-sheep erytbrocyte (SRC) plaque assay (13). Protein A was prepared for us by Dr. H. 
Wigzell, Biomedicum,  University of Uppsala,  Uppsala,  Sweden,  or commercially obtained 
from Pharmacia AB, Uppsala, Sweden. Antibodies against purified MOPC  104E  19S IgM 0~, 
/L) against MOPC21 IgG (','1,  J¢), and against PC-5 IgGz (Y2, to) were raised in rabbits by repeated 
injections of 0.5-1  mg of the myeloma protein in incomplete Freund's adjuvants and titrated 
for  their optimal developing capacity in  the  plaque  assay with  myeloma protein-secreting 
myeloma cell lines and with LPS-stimulated spleen cells. Complement was from Gibco Bio- 
Cult. Plaque assays specific for trinitrophenyl-substituted SRC (TNP30-SRC), horse ecythrocytes 
(HRC),  or SRC  were  done  as  described previously (5)  and  detected  IgM-secreting, direct, 
specific PFC. 
Results 
Growth Induction of Small, Resting B  Cells by PPD Tuberculin and by LPS.  Spleen cells 
of C57BL/6J  nu/nu  mice  were  separated  by  velocity sedimentation  (11,  14)  into 
small, resting cells and  into medium- and  large-size cells (Materials and  Methods). 
The separated small cells were thereafter cultured in the absence or presence of PPD 
tuberculin or LPS in a  modified Dulbecco's medium containing the serum substitutes 
transferrin,  serum  albumin,  and  lipids  (12)  to  increase  survival  of lymphocytes  in 
culture and to exclude possible mitogens contained in serum. For 5 d  thereafter, cells 
were counted in a  hemocytometer. Small- and large-size cells were distinguished. 
Fig.  1 c shows that in the absence of added mitogen, the cells remained small, and 
the  cell  concentration  remained  practically  constant  over  the  5-d  period.  In  the 
presence of LPS  (Fig.  1 a),  the number  of small cells dropped within  a  day by one- 
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F[c.  I.  Blast transformation and growth of small, resting B cells by PPD tuberculin and by LPS. 
4.2  ×  106 small splenic lymphocytes/ml from C57BL/6J  nu/nu  mice were cultured with LPS (50 
~g/ml)  (a),  PPD  (100  /~g/ml)  (b),  or  with  no  additions  (c).  Cells were counted  each  day  and 
distinguished under the microscope for large (O) and small (0) cells. 
small  cells  in  the  LPS-containing  cultures  could  nearly  be  accounted  for  by  the 
number of cells (~ 1 ×  105/ml) initiating growth, and thereby, becoming blasts. The 
number of blast  cells increased  exponentially up  to day 5,  a  result  expected from 
previous results of LPS-induced B-cell growth (3). Consequently the total number of 
cells in culture increased up to day 5. 
In the presence of PPD tuberculin, a drop in the number of small cells within the 
first 24 h  of stimulation similar to that observed with LPS could be seen  (Fig.  1 b). 
However, the total number of cells remained  ,nstant and did not increase over the 
5-d period. Approximately the same number o5 blast  cells appeared within 24 h  of 
stimulation as it had been observed in the LPS-stimulated cell cultures. These PPD 
tuberculin-induced blasts,  however, apparently did not grow because their number 
remained practically constant for the next 4 d. The size of these blasts increased with 
time of stimulation. 
PPD tuberculin-induced B-cell blasts also did not incorporate significant amounts 
of [3H]thymidine into DNA, very much like the unstimulated cell population, and in 
contrast to LPS-induced [3H]thymidine uptake in such stimulated cells (Table I). 
We conclude that PPD tuberculin induces blast transformation in a part, approx- 
imately one-third to one-fourth, of all small, resting splenic lymphocytes of C57BL/ 
6J nu/nu mice, but does not initiate growth of these cells. 
Induction  of  Small,  Resting  B  Cells  to  Ig  Secretion  by  PPD  Tuberculin  and  by 
LPS.  Separated, small, resting spleen cells of C57BL/6J nu/nu mice were induced, 
as expected, by LPS to the development of IgM-PFC in numbers comparable to those 
observed in previous experiments (12)  (Fig. 2). Approximately 10% of all blast cells 1342  PURIFIED PROTEIN  DERIVATIVE OF TUBERCULIN 
TABLE  I 
Uptake of [aH] Thymidine into Acid-insoluble Material  by Small B  Cells 
Stimulated for 48 and 72 h with PPD Tuberculin or LPS 
Mitogen 
[3H]Thymidine uptake 
Day 2 of stimulation  Day 3 of stimulation 
cpm/l  X  105 plated cells 
None  60 + 20  50 _  15 
LPS  10,600 + 700  48,500 + 2,500 
PPD tuberculin  450 +  100  300 +  150 
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FIG. 2.  Induction  of IgM-secreting  PFC  in cultures  of small, resting C57BL/6J  nu/nu splenic 
lymphocytes stimulated with LPS (50 #g/m[, A) or PPD tuberculin  (100 #g/ml, 0). Control:  no 
mitogen added (C)). Initial cell concentration in culture was 4.2 x  105 cells/ml. 
growing in these cultures, therefore, could be detected as an IgM-PFC (compare Fig. 
1 a  with Fig. 2). The problem of B cells secreting Ig vs. those not secreting Ig in such 
cultures has been observed and discussed previously (9). 
In the absence of mitogen, no IgM-PFC developed above the original background 
of the  cell  preparation.  At  day  4  and  5  of stimulation,  PPD  tuberculin  induced 
between 5 and  10% of the number of IgM-PFC observed in LPS-stimulated cultures. 
The medium- and large-size cells in these cultures, purified by velocity sedimentation, 
were  the  Ig-secreting cells  (data  not  shown).  5-10%  of them  actually  produced  a JAN ANDERSSON, WALDEMAR LERNHARDT, AND FRITZ MELCHERS  1343 
plaque  (for this problem, see above), and the repertoire of these secreting cells was 
found to be polyclonal. Thus,  1 in 2 ×  10  a PPD tuberculin-induced IgM-PFC were 
SRC specific,  1 in 450 HRC specific, and  1 in  100 TNPs0-SRC specific; very much 
like the repertoire of LPS-induced IgM-PFC obtained after growth and maturation 
and as published previously (5). Of all blast cells in these cultures (Fig.  1 b)  ~5-10% 
could be detected as IgM-PFC. 
PPD tuberculin also induced small,  resting cells into cells secreting IgG1  and/or 
IgG2, detected in the protein A-SRC plaque assay (Materials and Methods) at day 5 
of stimulation.  Compared  with  the  LPS-induced  maturation  to  IgG1-  and  IgG2- 
secreting cells (7.5 ×  104 PFC/4 ×  105 plated cells) PPD tuberculin stimulated much 
fewer such cells  (1  ×  103 PFC/4  ×  105 plated  cells).  Compared  to the  number of 
PPD tuberculin-induced IgM-PFC (- 104/4 ×  105 cultured cells [Fig. 2]) the number 
of PPD  tuberculin-induced IgG1-  and  IgG2-secreting cells  (1  ×  10a/4  ×  105) was 
10%. 
We  conclude  that  PPD  tuberculin,  although  not  stimulating  growth  of small, 
resting  B  cells,  induces  polyclonal  maturation  to  blast-like,  large  IgM-  and  IgG- 
secreting cells. 
Growth Stimulation of Activated B-Cell Blasts by PPD Tuberculin and by LPS.  Activated 
B-cell blasts  can  be  generated  from resting  B  cells of spleen  in  a  48-h  incubation 
period with B-cell mitogens such as LPS (9). They can be separated from nonactivated 
small  cells by velocity sedimentation.  Such  LPS-activated B-cell blast  populations 
contain  >98%  Ig+  cells  and  are,  therefore,  highly  enriched.  Another  source  of 
activated  B-cell  blasts  are  the  medium-  and  large-size  cells  of spleen,  which  are, 
however, contaminated by large cells of other origins, such as macrophages etc. Both 
types of B-cell blasts need the presence of the growth-stimulating mitogens early after 
division in the cell cycle to go through the next round of division. This requirement 
in each cell cycle of a growing clone of B cells has been used previously to assay given 
B-cell blast populations for their reactivities toward several different B-cell mitogens 
(9).  The same experimental principle of restimulation of growth and maturation is 
used  here  to  study  the  growth-  and  maturation-stimulating  properties  of  PPD 
tuberculin with LPS-activated and with background-activated B-cell blasts. 
LPS-activated B-cell blasts were cultured in the absence or presence of LPS (the 
homologous mitogen) as controls, or in the presence of PPD tuberculin. Growth and 
induction to IgM-PFC was measured (Fig. 3). 
The  numbers  of growing  cells  and  the  numbers  of IgM-PFC  induced  by  PPD 
tuberculin compared to the homologous mitogen LPS show that approximately one- 
half of the LPS-induced B-cell blasts can continue to grow and  to mature  to IgM 
secretion in  the presence of the heterologous B-cell mitogen  PPD  tuberculin. Two 
conclusions can  be reached  from these  results:  (a)  B-cell blasts  generated by LPS- 
activation of resting C57BL/6J nu/nu  spleen cells  (6-8 wk old)  contain more than 
one mitogen reactivity for, and therefore probably more than one receptor for LPS 
and  for PPD tuberculin and  (b)  PPD tuberculin, although unable to activate and 
stimulate  resting  B  cells  to  growth,  is  able  to  stimulate  activated  B-cell  blasts  to 
growth and secretion. 
Medium- and large-size cells, enriched from spleen cells by velocity sedimentation, 
were also tested for their susceptibility to stimulation by PPD tuberculin. There was 
a minor increase in the total number of cells in culture, as a result of the fact that the 1344  PURIFIED  PROTEIN  DERIVATIVE  OF  TUBERCULIN 
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FXC~.  3.  Induction of growth (left)  and of IgM-secreting PFC  (right) in cultures of 48-h-activated 
LPS-B-cell blasts restimulated with LPS (A), PPD tuberculin (O), or no mitogen added (O). Initial 
cell concentration in culture was 1.8 ×  105 blasts/ml. 
medium-  and  large-size cells of spleen  contain  many  non-B  cells.  PPD  tuberculin 
induced, over a  5-d period of stimulation, numbers of IgM-PFC  (7  ×  104 PFC/3 X 
105 plated cells)  in cultures of medium- and large-size cells from C57BL/6J nu/nu 
spleen comparable to those induced by LPS (8 ×  104 PFC/3 X  105 plated cells). In 
the absence of any added mitogen, the number of IgM-PFC remained more or less 
constant (1.5  ×  103 PFC/3 ×  10  ~ plated cells). 
Frequencies of PPD  Tuberculin-  and  of LPS-reactive  Cells  in  Small,  Resting  B  cells, 
Background-activated Spleen Cells, and LPS-activated B-Cell Blasts.  The number of mito- 
gen-reactive B cells giving rise to a clone to IgM-PFC can be determined by limiting- 
dilution analysis in cultures by limiting the number of reactive B cells to one, under 
conditions where every growth-inducible B cell (resting or blast) will be able to grow 
and mature into a clone of secreting cells (2). Such clones of secreting cells, developed 
in medium containing thymus filler cells and the appropriate mitogen (LPS or PPD 
tuberculin) are detected by the protein A-SRC plaque assay. 
Table  II  summarizes  the  frequency analyses  for LPS-  and  for PPD  tuberculin- 
reactive B cells in resting, background-activated, and LPS-activated splenic B cells of 
C57BL/6J nu/nu mice. The frequencies are approximate, because only 3.3-fold step 
dilutions  in  cell concentrations were assayed.  The results show,  with  the  accuracy 
obtainable with such an analysis, that:  (a) Small, resting B cells are not activated to 
clonal growth of IgM-secreting cells by PPD tuberculin (i.e., <1  in  103 resting B cells 
are activated to a  clone of IgM-secreting cells by PPD tuberculin).  (b) Activated B 
cells  are  stimulated  to  clonal  growth  of IgM-secreting  cells  by  PPD  tuberculin. 
Approximately 1 of 10-30 background-activated, large spleen cells, and  1 of 2 LPS- 
activated B cells do so. JAN  ANDERSSON,  WALDEMAR  LERNHARDT,  AND  FRITZ  MELCHERS 
TABLE  II 
Approximate Frequencies  of LPS- and PPD Tuberculin-reactive Cells * 
1345 
Cells~  Mitogen 
Frequency of mito- 
gen-reactive cells 
yielding a clone of 
IgM-PFC 
Small, resting spleen cells 
Large, background-activated splenic blasts 
Large, LPS-activated B-cell blasts 
LPS  1 in 5 ×  l0  ° 
PPD  1 in  1 ×  10  s 
None  <  1 in  1 ×  104 
LPS  1 in 5 ×  101 
PPD  1 in 5 ×  10  2 
None  <  1 in  1 ×  10  a 
LPS  1 in  1 ×  10  ° 
PPD  1 in  1 ×  10 I 
None  <  lin  1 ×  10  s 
* Limiting-dilution analyses in 3.3-fold dilutions of B cells in medium containing 3 ×  lO  6 rat 
thymocytes/ml and  the appropriate  mitogen were done as described previously  (2,  4). 
Blasts were assayed at day 3 of restimulation. Average size of a single clone from small B 
cells ranged between 30 and  120 IgM-seereting PFC. Average size of a  single clone from 
large cells or from blasts ranged between 6 and 30 IgM-secreting.  PFC. 
:]: All cells were C57BL/6J nu/nu. 
TABLE  III 
Mitogenicity of Different Batches of PPD Tuberculin at Different Concentrations with Small, Resting B 





Batch R523, lot 9  Batch 38, lot 8  Batch 33, lot 29 
Small  Small  Small cells  Blasts  Blasts  Blasts  cells  cells 
~g/ml  × lO-~IgM-secreting  PFC/lOncultured  cel~ 
1  5  10  2  18  2  18 
3  10  15  3  10  1  15 
10  20  30  10  35  2  30 
30  150  120  25  100  5  100 
100  400  350  65  420  l0  310 
300  400  400  55  300  10  300 
1,000  80  95  15  70  3  80 
* Assay with small cells at day 4 of culture, with LPS-activated B-cell blasts at day 3 of culture. 
~: Control cultures containing 50 #g/ml LPS yielded 2  X  104 IgM-PFC  from small cells and  2.5  X  104 
IgM-PFC from LPS-activated blasts. The corresponding controls containing no mitogen yielded 2 X  102 
IgM-PFC and 5 ×  102 IgM-PFC, respectively. 
The Mitogenic Activity of Different Batches of PPD Tuberculin.  Three  different  batches 
of  PPD  tuberculin,  all  from  Statens  Serum  Institute,  were  assayed  at  different 
concentrations  with  small,  resting  B  cells  and  with  LPS-activated  B-cell  blasts  for 
induction  of growth  and  maturation  into IgM-secreting  cells. 
Results  in Table  III  show  that  different  batches  of PPD  tuberculin  have  different 
properties.  One  batch  activates  resting  B  cells  to  growth  almost  as  well  as  LPS- 
activated  B-cell  blasts,  a  second  has  a  reduced,  but  measurable  activating  influence 1346  PURIFIED  PROTEIN  DERIVATIVE OF  TUBERCULIN 
on resting cells, whereas a  third, which was used throughout  the studies reported in 
this paper (above), has no measurable activating capacity for resting cells.  As seen 
from the data, this is so at concentrations of PPD tuberculin  between  1 mg/ml and 
1 /~g/ml.  All  batches  activate LPS-induced  B-cell  blasts equally  well.  The optimal 
stimulatory capacity for B-blasts is between  100 and 300/~g/ml PPD tuberculin. 
It is evident that some PPD tuberculin batches will have to be purified to separate 
mitogens that stimulate resting, as well as activated cells from mitogens that stimulate 
only activated cells. 
Discussion 
B-cell mitogens have been defined as molecules which have the property of inducing 
the growth of B-cell clones in a  polyclonal fashion, irrespective of the specificities of 
VH/VL-regions expressed in the mitogen-reactive B cells and their clonal descendants. 
Most  mitogens  so  far  studied  will  also  induce  B-cell  maturation  to  Ig  secretion. 
Conditions can be found in which only growth, but no maturation into Ig secretion 
(15), or no growth, and only maturation into Ig secretion (16), can be observed after 
mitogenic  stimulation.  The  latter,  maturation  without  growth,  was  so  far  only 
observed  with  normal  lymphocytes  when  DNA-synthesis  was  inhibited  through 
inhibition of the deoxynucleotide metabolism of the B cell. 
The results in this paper, for the first time, define a  B-cell mitogen as a polyclonal 
activator for maturation to Ig secretion only. The improved tissue-culture conditions 
allow  even  the  detection  of  IgG-secreting cells  in  the  absence  of growth,  which 
indicates that the switch from IgM to IgG synthesis and secretion observed in single 
clones of mitogen-activated B cells (17) may occur without cell division and in a single 
cell stimulated by PPD tuberculin to maturation only. 
Maturation  into Ig secretion has previously been  found to be antagonistic  to the 
growth  of  B  cells.  Induction  to  maturation  effected  by  such  mitogens  as  PPD 
tuberculin  may, therefore, delete the activated B cell from the repertoire of growth- 
inducible B cells of the system and may, thereby, constitute suppression or deletion of 
such B cells. It seems premature to speculate on the physiological role of such mitogens 
as long as the  connections of mitogenicity, antigen  specificity, and  possible further 
requirements  in  immune reactions  leading  to  stimulation  or suppression  of B-cells 
have not been further clarified. 
Earlier  experiments,  performed  under  conditions  where  there  were  very limited 
possibilities for murine  B  lymphocytes to  grow and  to mature to  Ig secretion  (18), 
identified  PPD  tuberculin  as  a  B-cell  mitogen  which  appeared  to  activate  B-cell 
subpopulations  characterized  as  late  in  their  development  to  Ig-secreting cells  (19, 
20).  Somewhat  in contrast  to these results,  it was found  in  other experiments,  that 
LPS and  PPD  tuberculin  activated  largely the  same B-cell  populations,  indicating 
that B cells could be reactive to more than one mitogen (20, 21). Our results presented 
in  this paper, i.e., that  LPS can stimulate resting B cells as well as activated B-cell 
blasts,  whereas  PPD  tuberculin  can  only stimulate  activated  B-cell  blasts,  but  not 
resting B cells, force us to reinterpret these earlier results. It appears now most likely 
that already activated, background B-cell blasts of spleen have been further stimulated 
under these earlier, more limited conditions of in vitro cultures.  This action of PPD 
tuberculin  on B cells would certainly support  the previous interpretation  that  PPD 
stimulated late B cells (20,  22), if one accepts an activated B-cell blast on its way to JAN ANDERSSON, WALDEMAR LERNHARDT, AND FRITZ MELCHERS  1347 
becoming a mature plasma cells as a distinct stage of B-cell development. 
Alternately,  it  is  possible  that  part  of the  earlier  discrepancies  in  experimental 
results were a  result of the  different mitogenic action of different batches of PPD 
tuberculin (see Table III). It is also not excluded that at the cell concentrations (i.e., 
5 ×  106 cell/ml) used in the earlier experiments, interactions of other cells with the 
resting B cells may render the resting B cells activated, and consequently susceptible, 
to  stimulation  by  PPD  tuberculin.  This  latter  possibility  will  have  to  be  probed 
experimentally with more-carefully purified, resting B-cell populations. 
Our studies on the action of PPD tuberculin on B cells have certainly been inspired 
by studies on T-cell activation  (23,  24).  In  these studies, it was shown  that  resting, 
small T-cells, carefully purified from B cells, activated large cells and macrophages 
could not be stimulated by mitogens (factors) contained in supernates ofconcanavalin 
A-treated spleen cells (23) unless these resting cells had previously been treated with 
antigen or with concanavalin A. Antigen, in this case allogeneic cells, or concanavalin 
A  alone,  on  the other hand,  did  not  stimulate  the  resting T  cells to  growth.  Our 
results  with  B  cells  and  their  activation  by  PPD  tuberculin  point  to  a  striking 
similarity in the distinction of a resting, from an activated, state of a lymphocyte and 
may suggest a similar mode of activation of T  and B cells by antigens plus mitogens. 
We have, on occasions, observed similar stimulatory effects with selected batches of 
fetal calfsera and transferrin preparations on activated B-cell blasts, whereas the same 
batches were nonstimulatory for resting cells. This appears of importance wherever B- 
cell  activation  by  cooperative  factors  and  by  anti-Ig  antibodies  is  studied  in  the 
presence of fetal calf serum (25, 26). In particular, exPerimental conditions should be 
critically assessed  for the  presence of PPD  tuberculin-like  mitogens,  whenever the 
action of anti-Ig antibodies on B cells leads to stimulation. 
T-cell dependent help in the antigen-specific activation and stimulation of resting 
B cells is another likely candidate for such a PPD tuberculin-like mitogen for B cells, 
whether  the  mitogen  itself  is  directly  supplied  by  T  cells,  or  indirectly  via  the 
activation of mitogen-producing third cells such as macrophages. Such action of T- 
cell  help  may  be  in  effect  where  in  vitro  differentiation  of human  leukemic  B 
lymphocytes to Ig-secreting plasma ceils has been observed (27). 
The cell cycle of growing eukaryotic cells is characterized by two events which are 
separated in time: ceil division (mitosis [M]) and DNA-synthesis (S-phase). The gap 
after M  and preceding S-phase is called Ga, the gap after S-phase and preceding M 
is called G2. Activated, growing B cells need the action ofa mitogen (such as LPS etc., 
9) after M  early in G1 to proceed through the next cell cycle and to complete M  (W. 
Lernhardt and F.  Melchers. Manuscript  in preparation.).  PPD tuberculin, as much 
as the commonly known B-cell mitogens LPS or LP (6, 7), is able to convey this type 
of mitogenesis to B cells. PPD tuberculin is, therefore, not deficient in its ability to 
stimulate  growth.  Because  PPD  tuberculin  is  able  to  do  so  with  a  large  number 
(approximately one-half) of all LPS-activated B-cell blasts, we have to conclude in 
close similarity to conclusions previously reached for LPS-, LP-, and NOC-reactive B 
cells (9), that a  majority (~50%) of all splenic B cells (of a C57BL/6J nu/nu mouse, 
6-8 wk of age) are reactive to more than one mitogen, now including PPD tuberculin, 
and, therefore, probably possess more than one mitogen receptor. It should be recalled 
here that a direct action of these B-cell mitogens on B cells, under circumvention of 
help  from T  cells or adherent  cells,  is  concluded from  the  finding that  growth  of 1348  PURIFIED  PROTEIN  DERIVATIVE OF  TUBERCULIN 
single clones of B cells in semi-solid media is dependent on the presence of such B-cell 
mitogens (28, 29). 
Resting cells do not synthesize DNA and do not divide. Their resting state has been 
called the G0-phase of the cell cycle. Activation of resting cells, i.e., of resting B cells 
by LPS, results in an activation of DNA-synthesis followed by M. From the G0-phase 
cells, therefore, B cells first enter the S-phase and  then G2-phase and  M  of the cell 
cycle. Thereafter, they proceed through Ga, S-phase, Gz, and M  and so on, as long as 
the stimulatory mitogen is present  (above). The results of this paper establish for B 
cells that G0-phase B cells require, in part, different, and probably more, signals to 
become activated and stimulated to growth than do activated B cells to enter the next 
cell cycle. Mitogens, such as PPD tuberculin, which do not activate resting G0-phase 
B  lymphocytes, but which will  stimulate  activated Gl-phase B-cell blasts,  pose the 
intriguing  problem  as  to  what  renders  a  resting  G0-phase  B  cell  susceptible  to 
stimulation by such Gl-phase-only mitogens. 
The most likely reaction which could render a  resting G0-phase B cell susceptible 
to  stimulation  by  Gl-phase-only  mitogens  is  the  binding  of antigen  to  surface  Ig 
molecules. This may induce changes in the surface membrane which may expose a 
functionally hidden  receptor for the  mitogen.  G0-Gl-phase mitogens,  such  as  LPS, 
LP, NOC, and mitogens in fetal calf serum, as a result of their lipophilic nature, may 
induce such changes in G0-phase B cells, by their very ability to insert themselves into 
the lipid bilayer of the B-cell surface membrane, which, of course, also contains the 
mitogen-specific receptors. Such a difference in action of G0-Gl-phase and Ga-phase- 
only  mitogens  may,  in  fact,  offer  an  explanation  for  the  observed  difference in 
activating potential between T-independent antigens of type 1 (hapten on LPS, LP, 
NOC, and Brucella abortus) and such of type 2 (pneumococcal polysaccharide, dextran, 
and levan). 
Finally, it appears still feasible to expect (30,  31)  that  recognitions by the B cells 
additional to the binding of antigen to surface Ig molecules, as i.e., of H-2-encoded 
molecules,  may  be  required  to  change  a  G0-phase  B  cell  to  its  activated  form 
susceptible for Gl-phase-only mitogens. 
Summary 
The purified protein derivative of tuberculin (PPD tuberculin) stimulates approx- 
imately one of two lipopolysaccharide (LPS)-activated B-cell blasts of C57BL/6J nu/ 
nu spleen cells to continued clonal growth and maturation to IgM and IgG secretion. 
It also stimulates background, in vivo-activated large cells of normal C57BL/6J nu/ 
nu spleen to growth and Ig secretion, at a  frequency of ~ 1 of 100 large spleen cells. 
PPD  tuberculin,  therefore, is  a  polyclonal  B-cell  activator for B-cell  blasts.  Many 
single  murine  splenic  B  cells  (~50%)  appear  to  have  reactivities,  and  therefore 
probably receptors, for LPS and PPD tuberculin. 
PPD tuberculin does not stimulate small, resting B cells to growth as measured by 
the  number  of cells  in  culture  and  by  thymidine  uptake.  However, it  stimulates 
approximately one-fourth of all  spleen cells to blast  transformation. The large-size 
blast  cells secrete IgM  and, therefore, form plaques  in  the protein A  plaque assay. 
IgG-secreting, plaque-forming cells develop at later stages of stimulation, indicating 
that the switch from IgM to IgG may occur without division in single, stimulated B 
cells.  Stimulation of resting B cells to maturation by PPD tuberculin is polyclonal. JAN  ANDERSSON,  WALDEMAR LERNHARDT,  AND FRITZ  MELCHERS  1349 
Thus, -  1 in 102 IgM-secreting plaque-forming cells form plaques with trinitrophenyl- 
substituted sheep erythrocytes,  1 in 450  do so with  horse erythrocytes, and  1 in  103 
with  sheep  erythrocytes.  Furthermore,  the  number  of Ig-secreting cells developing 
from small, resting cells without growth in cultures with or without filler thymus cells 
suggests polyclonal activation by PPD  tuberculin to maturation only of at least one 
out of four small, splenic B  cells. 
The able technical assistance of Mrs. Deborah Norman is gratefully acknowledged. 
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